We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Centene's Illinois Medicaid Renewal: A Win for Long-Term Growth?
Read MoreHide Full Article
Key Takeaways
CNC's Meridian won a four-year Illinois Medicaid contract renewal through 2030 under HealthChoice Illinois.
CNC's renewal preserves a major membership base, supporting premium revenue visibility and growth stability.
Centene's Medicaid revenues rose 6% year over year to $23.6 billion in first-quarter 2026.
Centene Corporation’s (CNC - Free Report) subsidiary, Meridian Health Plan of Illinois, has secured a four-year renewal of its contract under the state's HealthChoice Illinois Medicaid program. The contract runs from Jan. 1, 2027, through 2030. Meridian is one of the six managed care organizations selected to provide services under the HealthChoice Illinois Medicaid program. The agreement ensures continued access to integrated primary, maternal and behavioral healthcare services for Medicaid members across Illinois.
Building on nearly 20 years of serving Illinois communities, Meridian continues to cover more than 596,000 Medicaid members. The renewal follows strong operational performance, with Meridian earning the state's highest 5-star rating on the latest HealthChoice Illinois Report Card for Access to Care, Living with Illness, and Women's and Children's Health. The agreement reinforces Centene's competitive position in the Illinois Medicaid market.
Medicaid remains Centene's largest business, with Medicaid revenues increasing 6% year over year to $23.6 billion in the first quarter of 2026. Given its heavy reliance on government-sponsored healthcare programs, the renewed Illinois contract supports premium revenue visibility and lowers the risk of future enrollment losses.
The announcement is not a game changer. It is unlikely to materially boost near-term earnings, but it preserves a significant source of premium revenues and enhances long-term earnings visibility. The renewal provides added confidence that Centene can maintain a stable Medicaid membership base and generate more predictable revenues from one of its core businesses.
How Are Competitors Faring?
Some of CNC's major competitors in the managed care space are Humana Inc. (HUM - Free Report) and Molina Healthcare, Inc. (MOH - Free Report) .
Humana also secured a statewide contract under Illinois' HealthChoice Illinois Medicaid program, reinforcing its presence in the state's Medicaid managed care market. The contract expands HUM's government-sponsored healthcare business and supports long-term membership growth. Even so, Medicaid is not as significant an earnings driver for HUM as it is for Centene.
Molina Healthcare relies heavily on state Medicaid contracts, which are a key driver of membership and premium revenues. MOH depends on retaining and expanding these contracts to sustain growth and earnings visibility. Continued success in state Medicaid procurements strengthens MOH's competitive position and supports long-term revenue stability.
Shares of CNC have rallied 64.3% in the year-to-date period compared with the industry’s growth of 28.5%.
Image Source: Zacks Investment Research
From a valuation standpoint, Centene trades at a forward price-to-earnings ratio of 17.09, below the industry average of 18.5. CNC carries a Value Score of A.
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for Centene’s 2026 earnings is pegged at $3.46 per share, implying 66.4% growth from the year-ago period’s level.
View the Zacks #1 Rank List
Image: Bigstock
Centene's Illinois Medicaid Renewal: A Win for Long-Term Growth?
Key Takeaways
Centene Corporation’s (CNC - Free Report) subsidiary, Meridian Health Plan of Illinois, has secured a four-year renewal of its contract under the state's HealthChoice Illinois Medicaid program. The contract runs from Jan. 1, 2027, through 2030. Meridian is one of the six managed care organizations selected to provide services under the HealthChoice Illinois Medicaid program. The agreement ensures continued access to integrated primary, maternal and behavioral healthcare services for Medicaid members across Illinois.
Building on nearly 20 years of serving Illinois communities, Meridian continues to cover more than 596,000 Medicaid members. The renewal follows strong operational performance, with Meridian earning the state's highest 5-star rating on the latest HealthChoice Illinois Report Card for Access to Care, Living with Illness, and Women's and Children's Health. The agreement reinforces Centene's competitive position in the Illinois Medicaid market.
Medicaid remains Centene's largest business, with Medicaid revenues increasing 6% year over year to $23.6 billion in the first quarter of 2026. Given its heavy reliance on government-sponsored healthcare programs, the renewed Illinois contract supports premium revenue visibility and lowers the risk of future enrollment losses.
The announcement is not a game changer. It is unlikely to materially boost near-term earnings, but it preserves a significant source of premium revenues and enhances long-term earnings visibility. The renewal provides added confidence that Centene can maintain a stable Medicaid membership base and generate more predictable revenues from one of its core businesses.
How Are Competitors Faring?
Some of CNC's major competitors in the managed care space are Humana Inc. (HUM - Free Report) and Molina Healthcare, Inc. (MOH - Free Report) .
Humana also secured a statewide contract under Illinois' HealthChoice Illinois Medicaid program, reinforcing its presence in the state's Medicaid managed care market. The contract expands HUM's government-sponsored healthcare business and supports long-term membership growth. Even so, Medicaid is not as significant an earnings driver for HUM as it is for Centene.
Molina Healthcare relies heavily on state Medicaid contracts, which are a key driver of membership and premium revenues. MOH depends on retaining and expanding these contracts to sustain growth and earnings visibility. Continued success in state Medicaid procurements strengthens MOH's competitive position and supports long-term revenue stability.
Centene’s Price Performance, Valuation & Estimates
Shares of CNC have rallied 64.3% in the year-to-date period compared with the industry’s growth of 28.5%.
Image Source: Zacks Investment Research
From a valuation standpoint, Centene trades at a forward price-to-earnings ratio of 17.09, below the industry average of 18.5. CNC carries a Value Score of A.
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for Centene’s 2026 earnings is pegged at $3.46 per share, implying 66.4% growth from the year-ago period’s level.
Image Source: Zacks Investment Research
CNC stock currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.